Farid Siddiqui

Proteomics- and BRET- screens identify SPRY2 as a Ras effector that impacts its membrane organization (2025)

iScience

Pavic, Karolina; Hood, Fiona Elizabeth; Duval, Carla Jane; Manoharan, Ganesh babu; Laurini, Christina; Siddiqui, Farid Ahmad; Mo, Stephanie Puy Lam; Prior, Ian Andrew; Abankwa, Daniel Kwaku

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Novel Small Molecule Hsp90/Cdc37 Interface Inhibitors Indirectly Target K-Ras-Signaling (2021)

Cancers

Siddiqui Farid Ahmad, Parkkola Hanna, Vukic Vladimir, Oetken-Lindholm Christina, Jaiswal Alok, Kiriazis Alexandros, Pavic Karolina, Aittokallio Tero, Salminen Tiina A., Abankwa Daniel

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Elaiophylin Is a Potent Hsp90/Cdc37 Protein Interface Inhibitor with K-Ras Nanocluster Selectivity (2021)

Biomolecules

Siddiqui Farid A., Vukic Vladimir, Salminen Tiina A., Abankwa Daniel

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

NRAS is unique among RAS proteins in requiring ICMT for trafficking to the plasma membrane (2021)

Life Science Alliance

Ahearn Ian M., Court Helen R., Siddiqui Farid, Abankwa Daniel, Philips Mark R.

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

FLIM-FRET Analysis of Ras Nanoclustering and Membrane-Anchorage (2021)

Parkkola Hanna, Siddiqui Farid Ahmad, Oetken-Lindholm Christina, Abankwa Daniel

(Vertaisarvioitu artikkeli kokoomateoksessa (A3))

Multiomics integrative analysis reveals antagonistic roles of CBX2 and CBX7 in metabolic reprogramming of breast cancer (2021)

Molecular Oncology

Iqbal Mohammad Askandar, Siddiqui Shumaila, Rehman Asad Ur, Siddiqui Farid Ahmad, Singh Prithvi, Kumar Bhupender, Saluja Daman

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

PDE6D Inhibitors with a New Design Principle Selectively Block K-Ras Activity (2020)

ACS Omega

Farid A. Siddiqui, Catharina Alam, Petja Rosenqvist, Mikko Ora, Ahmed Sabt, Ganesh babu Manoharan, Lakshman Bindu, Sunday Okutachi, Marie Catillon, Troy Taylor, Omaima M. Abdelhafez, Harri Lönnberg, Andrew G. Stephen, Anastassios C. Papageorgiou, Pasi Virta, Daniel Abankwa

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

A subset of flavaglines inhibits KRAS nanoclustering and activation (2020)

Journal of Cell Science

Yurugi H, Zhuang YY, Siddiqui F, Liang H, Rosigkeit S, Zeng YP, Abou-Hamdan H, Bockamp E, Zhou Y, Abankwa D, Zhao WT, Desaubry L, Rajalingam K

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications (2020)

FEBS Journal

Mohammad Askandar Iqbal, Shilpi Chattopadhyay, Farid Ahmad Siddiqui, Asad Ur Rehman, Shumaila Siddiqui, Gopinath Prakasam, Asifa Khan, Sarwat Sultana, Rameshwar NK Bamezai

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Medium-Throughput Detection of Hsp90/Cdc37 Protein-Protein Interaction Inhibitors Using a Split Renilla Luciferase-Based Assay (2019)

SLAS discovery

Farid Ahmad Siddiqui, Hanna Parkkola, Ganesh babu Manoharan, Daniel Abankwa

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Farid

Siddiqui

Contact

Publications

Sort by:

Proteomics- and BRET- screens identify SPRY2 as a Ras effector that impacts its membrane organization (2025)

Novel Small Molecule Hsp90/Cdc37 Interface Inhibitors Indirectly Target K-Ras-Signaling (2021)

Elaiophylin Is a Potent Hsp90/Cdc37 Protein Interface Inhibitor with K-Ras Nanocluster Selectivity (2021)

NRAS is unique among RAS proteins in requiring ICMT for trafficking to the plasma membrane (2021)

FLIM-FRET Analysis of Ras Nanoclustering and Membrane-Anchorage (2021)

Multiomics integrative analysis reveals antagonistic roles of CBX2 and CBX7 in metabolic reprogramming of breast cancer (2021)

PDE6D Inhibitors with a New Design Principle Selectively Block K-Ras Activity (2020)

A subset of flavaglines inhibits KRAS nanoclustering and activation (2020)

Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications (2020)

Medium-Throughput Detection of Hsp90/Cdc37 Protein-Protein Interaction Inhibitors Using a Split Renilla Luciferase-Based Assay (2019)